Osteoporosis Causes Symptoms Diagnosis and Treatment Guide
Orthopedics

Osteoporosis Causes Symptoms Diagnosis and Treatment Guide

Definition

Osteoporosis is a chronic metabolic bone disease characterized by low bone mass, microarchitectural deterioration of bone tissue, and increased bone fragility, leading to a higher risk of fractures, especially in the hip, spine, and wrist.


Pathophysiology

  • Bone remodeling normally balances bone formation (osteoblasts) and bone resorption (osteoclasts)
  • In osteoporosis:

* Bone resorption exceeds bone formation

* Loss of bone density and structural strength occurs

  • Estrogen deficiency, aging, hormonal imbalance, nutritional deficiencies, and inactivity accelerate bone loss

Causes and Risk Factors

Primary Osteoporosis

  • Postmenopausal estrogen deficiency
  • Age-related bone loss (senile osteoporosis)
  • Genetic predisposition

Secondary Osteoporosis

  • Endocrine disorders: Hyperthyroidism, Cushing syndrome, diabetes
  • Chronic kidney or liver disease
  • Rheumatoid arthritis
  • Malabsorption syndromes (celiac disease)
  • Cancer and chemotherapy

Medication-Induced

  • Long-term corticosteroids
  • Anticonvulsants
  • Heparin
  • Aromatase inhibitors

Lifestyle and Nutritional Causes

  • Low calcium and vitamin D intake
  • Smoking and alcohol abuse
  • Sedentary lifestyle
  • Low body weight
  • Poor sunlight exposure

Clinical Features (Symptoms)

Early Stage

  • Often asymptomatic (silent disease)

Progressive Symptoms

  • Bone pain (especially back pain)
  • Fragility fractures (fracture after minor trauma)
  • Loss of height
  • Kyphosis (stooped posture / dowager’s hump)
  • Reduced mobility

Common Fracture Sites

  • Hip
  • Vertebrae (spine)
  • Wrist (Colles fracture)

Complications

  • Hip fractures leading to disability
  • Chronic back pain
  • Spinal deformity
  • Reduced quality of life
  • Increased mortality after major fractures

Investigations and Diagnosis

Bone Mineral Density (Gold Standard)

  • DEXA scan

* T-score ≥ −1: Normal

* T-score −1 to −2.5: Osteopenia

* T-score ≤ −2.5: Osteoporosis

Laboratory Tests

  • Serum calcium, phosphate
  • Vitamin D levels
  • Parathyroid hormone
  • Thyroid function tests
  • Renal and liver function tests

Imaging

  • X-ray (vertebral fractures)
  • MRI/CT if fracture suspected

Differential Diagnoses

  • Osteomalacia
  • Paget’s disease of bone
  • Bone metastasis
  • Rheumatoid arthritis
  • Multiple myeloma

Management and Treatment (Comprehensive)

1. Lifestyle and Non-Pharmacologic Measures

  • Weight-bearing exercises (walking, resistance training)
  • Adequate sunlight exposure
  • Smoking cessation
  • Alcohol reduction
  • Fall prevention strategies
  • Balanced diet rich in calcium and protein

2. Calcium and Vitamin D Supplementation

Calcium

  • Indication: Bone mineral support
  • Dose: 1000–1200 mg/day (diet + supplements)
  • Adverse Effects: Constipation, kidney stones
  • Contraindications: Hypercalcemia

Vitamin D (Cholecalciferol)

  • Dose: 800–2000 IU/day
  • Role: Improves calcium absorption
  • Monitoring: Serum vitamin D levels

3. Pharmacologic Treatment

A. Bisphosphonates (First-Line)

Examples: Alendronate, Risedronate, Zoledronic acid

  • Mechanism: Inhibits osteoclast-mediated bone resorption
  • Dose: Alendronate 70 mg once weekly
  • Adverse Effects: GI irritation, osteonecrosis of jaw (rare)
  • Contraindications: Esophageal disorders, severe renal impairment

B. Denosumab

  • Mechanism: Monoclonal antibody inhibiting osteoclast activity
  • Dose: 60 mg SC every 6 months
  • Adverse Effects: Hypocalcemia, infection risk
  • Indication: Postmenopausal osteoporosis, high fracture risk

C. Selective Estrogen Receptor Modulators (SERMs)

Example: Raloxifene

  • Mechanism: Estrogen-like effect on bone
  • Benefit: Reduces vertebral fractures
  • Risk: Thromboembolism

D. Hormone Replacement Therapy (HRT)

  • Used in postmenopausal women
  • Benefits bone density
  • Risks: Breast cancer, cardiovascular disease

E. Parathyroid Hormone Analogs

Example: Teriparatide

  • Mechanism: Stimulates new bone formation
  • Indication: Severe osteoporosis
  • Duration: Max 2 years

F. Calcitonin

  • Reduces bone resorption
  • Provides pain relief in vertebral fractures

4. Fracture Management

  • Surgical repair (hip fractures)
  • Pain control
  • Physical rehabilitation
  • Fall prevention programs

Prevention Strategies

  • Adequate calcium and vitamin D intake from early adulthood
  • Regular physical activity
  • Early screening after age 50 or high-risk individuals
  • Minimizing long-term steroid use

Prognosis

  • Early diagnosis and treatment reduce fracture risk
  • Untreated osteoporosis leads to progressive disability
  • Lifelong management improves bone strength and quality of life

Interactive MCQ Quiz

MCQ Exam Mode

15 Questions
Question 1 of 15

Frequently Asked Questions

Osteoporosis is a bone disease characterized by decreased bone density and structural weakness, increasing the risk of fractures.
Causes include aging, postmenopausal estrogen deficiency, long-term steroid use, poor calcium and vitamin D intake, sedentary lifestyle, and genetic factors.
Postmenopausal women, elderly individuals, people with low body weight, smokers, chronic steroid users, and those with hormonal disorders are at higher risk.
Osteoporosis is often asymptomatic in early stages until fractures occur; early signs may include mild back pain and gradual height loss.
Common complications include hip fractures, vertebral compression fractures, chronic back pain, spinal deformity, disability, and increased mortality.
The gold standard diagnostic test is a DEXA scan, which measures bone mineral density and provides a T-score.
A T-score of −2.5 or lower confirms the diagnosis of osteoporosis.
Regular weight-bearing exercise, adequate calcium and vitamin D intake, smoking cessation, limiting alcohol, and fall prevention strategies help prevent osteoporosis.
Bisphosphonates such as alendronate are the first-line pharmacologic treatment to reduce bone resorption and fracture risk.
Alternatives include denosumab, raloxifene, teriparatide, and hormone replacement therapy depending on patient profile.
Vitamin D improves calcium absorption and supports bone mineralization, reducing bone loss.
A fragility fracture is a bone fracture that occurs after minor trauma due to weakened osteoporotic bones.
Bone loss cannot be fully reversed, but treatment can significantly improve bone density and reduce fracture risk.
DEXA scanning is usually recommended every 1–2 years in high-risk individuals or those on treatment.
A diet rich in calcium, vitamin D, protein, leafy greens, dairy products, and fortified foods supports bone health.
Yes, men can develop osteoporosis, especially with aging, hypogonadism, alcohol use, or long-term medication use.
Long-term corticosteroids, anticonvulsants, heparin, aromatase inhibitors, and excessive thyroid hormone increase osteoporosis risk.
Teriparatide stimulates osteoblast activity, promoting new bone formation and improving bone strength.
Sudden back pain, height loss, spinal curvature, hip pain after minor falls, and reduced mobility are warning signs.
Home safety modifications, balance training, vision correction, proper footwear, and strength exercises reduce fall risk.